Ophthalmology Innovation Summit
Ophthalmology Innovation Summit
November 17, 2017
1 min watch

VIDEO: Aura hopes to bring first ocular melanoma treatment to fruition

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Elisabet de los Pinos, PhD, CEO of Aura Biosciences, discusses the work the company is doing to bring its treatment for ocular melanoma using viral nanoparticle conjugates to the U.S.